Join to view full profile
19229 Mack AveGrosse Pointe Woods, MI 48236
Phone+1 800-848-0202
Fax+1 586-226-6949
Dr. Lorenzana is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Adonis Lorenzana is a pediatric hematology and oncology specialist based in Grosse Pointe Park, MI. He completed his fellowship in pediatric hematology/oncology at the University of Chicago and his pediatrics residency at Oschenr Clinic and hospitals in New Orleans (affiliation with Louisiana State University School of Medicine) Dr. Lorenzana has contributed to several publications, including studies on treatments and outcomes in pediatric hematology/Oncology. He was involved in clinical trials such as ICON1, which focuses on treatment decisions in pediatric refractory ITP. He also participated in many clinical trials through the Chjildren's Oncology Group. He holds the title of Super Doctor from SuperDoctors.com and is a Fellow of the American Academy of Pediatrics.
Education & Training
University of ChicagoFellowship, Pediatric Hematology/Oncology, 1988 - 1991
Louisiana State University School of MedicineResidency, Pediatrics, 1985 - 1988
Universidad Nacional Autonoma de Honduras Class of 1982
Certifications & Licensure
MI State Medical License 1996 - 2028
WV State Medical License 2026 - 2028
LA State Medical License 2023 - 2024
NM State Medical License 2008 - 2008
IL State Medical License 1988 - 1993
OK State Medical License 1988 - 1988
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsProlonged remission in multiple relapsed MLL-rearranged infant B-ALL with inotuzumab ozogamicin.Akhila Lattupally, Adonis Lorenzana, Gregory Anthony Yanik, Danielle Bell
Pediatric Blood & Cancer. 2023-04-01 - 35 citationsSecond-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomesRachael F. Grace, Kristin A. Shimano, Rukhmi Bhat, Cindy Neunert, James B. Bussel
American Journal of Hematology. 2019-07-01 - 28 citationsPhysician decision making in selection of second-line treatments in immune thrombocytopenia in childrenRachael F. Grace, Jenny M. Despotovic, Carolyn M. Bennett, James B. Bussel, Michelle Neier
American Journal of Hematology. 2018-07-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
